Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Reproductive factors, hormones and colorectal cancer-still unresolved.

Rennert G.

Br J Cancer. 2017 Jan 3;116(1):1-3. doi: 10.1038/bjc.2016.388. Epub 2016 Nov 29. No abstract available.

PMID:
27898659
2.

Menstrual and Reproductive Factors and Risk of Gastric and Colorectal Cancer in Spain.

Lope V, Fernández de Larrea N, Pérez-Gómez B, Martín V, Moreno V, Costas L, Longo F, Jiménez-Moleón JJ, Llorca J, Ascunce N, Peiró-Pérez R, Altzibar JM, Tardón A, Alguacil J, Navarro C, Sierra Á, Vega AB, Villafañe A, Castaño-Vinyals G, Kogevinas M, Pollán M, Aragonés N.

PLoS One. 2016 Oct 24;11(10):e0164620. doi: 10.1371/journal.pone.0164620. eCollection 2016.

3.

Reproductive history and risk of colorectal adenocarcinoma in parous women: a Nordic population-based case-control study.

Bjørge T, Gissler M, Ording AG, Engeland A, Glimelius I, Leinonen M, Sørensen HT, Tretli S, Ekbom A, Troisi R, Grotmol T.

Br J Cancer. 2016 Nov 22;115(11):1416-1420. doi: 10.1038/bjc.2016.315. Epub 2016 Oct 4.

4.

Vitamin D intake, serum Vitamin D levels, and risk of gastric cancer: A systematic review and meta-analysis.

Khayatzadeh S, Feizi A, Saneei P, Esmaillzadeh A.

J Res Med Sci. 2015 Aug;20(8):790-6. doi: 10.4103/1735-1995.168404. Review.

5.

Oral contraceptive use and colorectal cancer in the Nurses' Health Study I and II.

Charlton BM, Wu K, Zhang X, Giovannucci EL, Fuchs CS, Missmer SA, Rosner B, Hankinson SE, Willett WC, Michels KB.

Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1214-21. doi: 10.1158/1055-9965.EPI-15-0172. Epub 2015 Jun 10.

6.

Assessing individual risk for high-risk colorectal adenoma at first-time screening colonoscopy.

Cao Y, Rosner BA, Ma J, Tamimi RM, Chan AT, Fuchs CS, Wu K, Giovannucci EL.

Int J Cancer. 2015 Oct 1;137(7):1719-28. doi: 10.1002/ijc.29533. Epub 2015 Apr 23.

7.

Oral contraceptives and menopausal hormone therapy: relative and attributable risks of cardiovascular disease, cancer, and other health outcomes.

Bassuk SS, Manson JE.

Ann Epidemiol. 2015 Mar;25(3):193-200. doi: 10.1016/j.annepidem.2014.11.004. Epub 2014 Nov 13.

8.

Oral contraceptive use and mortality after 36 years of follow-up in the Nurses' Health Study: prospective cohort study.

Charlton BM, Rich-Edwards JW, Colditz GA, Missmer SA, Rosner BA, Hankinson SE, Speizer FE, Michels KB.

BMJ. 2014 Oct 31;349:g6356. doi: 10.1136/bmj.g6356.

9.

Combined hormonal contraceptives: prescribing patterns, compliance, and benefits versus risks.

Brynhildsen J.

Ther Adv Drug Saf. 2014 Oct;5(5):201-13. doi: 10.1177/2042098614548857. Review.

10.
11.

Hormonal anticonception anno 2013: a clinician's view.

Dhont M, Verhaeghe V.

Facts Views Vis Obgyn. 2013;5(2):149-59.

12.

Age at menarche and risk of colorectal cancer: a meta-analysis.

Li CY, Song B, Wang YY, Meng H, Guo SB, Liu LN, Lv HC, Wu QJ.

PLoS One. 2013 Jun 6;8(6):e65645. doi: 10.1371/journal.pone.0065645. Print 2013.

13.

The clinical consequences of an ageing world and preventive strategies.

Lunenfeld B, Stratton P.

Best Pract Res Clin Obstet Gynaecol. 2013 Oct;27(5):643-59. doi: 10.1016/j.bpobgyn.2013.02.005. Epub 2013 Mar 28.

14.

Abdominal obesity, independent from caloric intake, accounts for the development of intestinal tumors in Apc(1638N/+) female mice.

Huffman DM, Augenlicht LH, Zhang X, Lofrese JJ, Atzmon G, Chamberland JP, Mantzoros CS.

Cancer Prev Res (Phila). 2013 Mar;6(3):177-87. doi: 10.1158/1940-6207.CAPR-12-0414.

15.

Reproductive, lifestyle, and anthropometric risk factors for cancer in elderly women.

Poynter JN, Inoue-Choi M, Ross JA, Jacobs DR Jr, Robien K.

Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):681-7. doi: 10.1158/1055-9965.EPI-12-0966. Epub 2013 Feb 19. Erratum in: Cancer Epidemiol Biomarkers Prev. 2013 Aug;22(8):1476-8.

16.

Hormonal contraception--what kind, when, and for whom?

Wiegratz I, Thaler CJ.

Dtsch Arztebl Int. 2011 Jul;108(28-29):495-505; quiz 506. doi: 10.3238/arztebl.2011.0495. Epub 2011 Jul 18.

17.
18.

Oral contraceptives, reproductive history and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition.

Tsilidis KK, Allen NE, Key TJ, Bakken K, Lund E, Berrino F, Fournier A, Olsen A, Tjønneland A, Overvad K, Boutron-Ruault MC, Clavel-Chapelon F, Byrnes G, Chajes V, Rinaldi S, Chang-Claude J, Kaaks R, Bergmann M, Boeing H, Koumantaki Y, Stasinopoulou G, Trichopoulou A, Palli D, Tagliabue G, Panico S, Tumino R, Vineis P, Bueno-de-Mesquita HB, van Duijnhoven FJ, van Gils CH, Peeters PH, Rodríguez L, González CA, Sánchez MJ, Chirlaque MD, Barricarte A, Dorronsoro M, Borgquist S, Manjer J, van Guelpen B, Hallmans G, Rodwell SA, Khaw KT, Norat T, Romaguera D, Riboli E.

Br J Cancer. 2010 Nov 23;103(11):1755-9. doi: 10.1038/sj.bjc.6605965. Epub 2010 Nov 2.

19.

Enhanced induction of mucin-depleted foci in estrogen receptor {beta} knockout mice.

Saleiro D, Murillo G, Lubahn DB, Kopelovich L, Korach KS, Mehta RG.

Cancer Prev Res (Phila). 2010 Sep;3(9):1198-204. doi: 10.1158/1940-6207.CAPR-10-0044. Epub 2010 Aug 17.

20.

Hormone replacement therapy, oral contraceptive use, and distal large bowel cancer: a population-based case-control study.

Long MD, Martin CF, Galanko JA, Sandler RS.

Am J Gastroenterol. 2010 Aug;105(8):1843-50. doi: 10.1038/ajg.2010.123. Epub 2010 Mar 30.

Supplemental Content

Support Center